Dermal fillers have evolved well beyond the simple gels that dominated the market for decades. A newer generation of so-called biostimulatory fillers does not merely occupy space under the skin; it is designed to provoke the patient’s own cells to rebuild the collagen scaffold that aging progressively dismantles. Polycaprolactone, often abbreviated PCL, has emerged as one of the leading materials in this class. It is slow to degrade, mechanically robust, and has a track record in approved collagen-stimulating products. Yet the microscopic details of how PCL particles interact with fibroblasts, the workhorse cells of the dermis, remain only partly understood, and manufacturers have largely relied on batch emulsion methods that produce particles with wide, poorly controlled size distributions.

The research group, led by Jintao Zhang and Lian Cen at East China University of Science and Technology, turned to droplet-based microfluidics to close that gap. In a microfluidic device, liquids are pushed through channels narrower than a human hair, and the interplay of flow rates, channel geometry and surface tension determines exactly when and how droplets pinch off. Because each droplet becomes one particle, the technique yields spheres of remarkably uniform diameter, a property known as monodispersity that conventional stirring-based emulsification cannot match. In this study, the researchers tuned the ratio of flow rates in the device to produce PCL microspheres of around 49 micrometers in diameter, a size range considered suitable for injection through fine needles while remaining large enough to persist in tissue.

The crucial innovation was the introduction of porosity. The team used tridecane, a simple hydrocarbon, as a porogen, a sacrificial agent that creates voids in the solidifying polymer. As the PCL droplets hardened, the tridecane was expelled in a way that left behind an interconnected porous architecture. The resulting porous microspheres, designated PM in the study, achieved a porosity of 78.19 percent, meaning more than three quarters of their apparent volume consisted of open space. For comparison, the researchers also prepared compact microspheres, designated SM, with smooth, dense surfaces and the same average size, allowing them to isolate the effect of surface texture from that of particle size or chemistry.

With both particle types in hand, the team subjected them to a battery of cell culture experiments using human skin fibroblasts, the cells responsible for synthesizing the collagen matrix that gives young skin its strength and elasticity. Both porous and compact microspheres proved highly biocompatible: fibroblasts grew on and around them, proliferated robustly, and showed no signs of the toxicity that can plague synthetic biomaterials. But the porous particles consistently outperformed their compact counterparts at the same concentration, stimulating greater fibroblast proliferation and, critically, greater secretion of both type I and type III collagen, the two fibrillar collagens most relevant to dermal structure and repair.

The dose mattered as well. The researchers systematically varied the concentration of microspheres in culture and identified 0.5 milligrams per milliliter as the optimal concentration for promoting collagen secretion. Below that level, the stimulatory effect was weaker; above it, no additional benefit was observed. This kind of dose-response mapping is exactly the information that translational developers need when formulating injectable products, since the concentration of particles in a filler suspension directly influences both its rheology and its biological activity after injection.

One of the more nuanced findings concerned inflammation. Interleukin-6, a signaling molecule often cast as a marker of harmful inflammation, was progressively upregulated in fibroblasts treated with either type of microsphere, with the porous particles producing a slightly stronger effect than the compact ones. The authors interpret this within the framework of regenerative signaling rather than pathology: transient, moderate IL-6 expression is part of the normal wound-healing and remodeling program, and many biostimulatory materials work precisely by engaging these pathways. The study thus adds a piece to the puzzle of how microsphere fillers trigger neocollagenesis, the formation of new collagen, without settling the deeper question of how to balance stimulatory inflammation against chronic irritation.

The implications reach beyond cosmetic dermatology. Porous micro- and nanoparticles are under intense investigation across regenerative medicine as cell carriers, drug depots and tissue-engineering scaffolds, and topographical cues, the physical texture of a biomaterial surface, are increasingly recognized as powerful regulators of cell behavior, sometimes rivaling biochemical signals. By demonstrating that a single manufacturing variable, surface porosity, measurably changes collagen output from human fibroblasts, the study strengthens the case that filler design should be treated as a materials-science problem as much as a formulation problem. It also aligns with parallel work on porous microspheres of poly-L-lactic acid, another biostimulatory polymer, which have been reported to act faster and produce fewer nodules than dense formulations.

The microfluidic platform itself may prove to be the study’s most exportable contribution. Because particle size in a droplet microfluidic device is governed by tunable flow rate ratios, the same hardware could, in principle, produce filler particles matched to different clinical indications: smaller spheres for superficial rhytids, larger ones for deep volume restoration. Monodispersity also promises more predictable degradation kinetics and more consistent biological response from batch to batch, addressing a longstanding criticism of emulsion-produced microsphere products. The authors describe their work as providing both a superior functional filler candidate and a detailed manufacturing technology, and the combination is what gives the paper its practical weight.

Considerable distance remains between cell culture dishes and clinic. The experiments reported here were conducted in vitro with a single cell type, and the immune environment of living skin, with its macrophages, vasculature and mechanical loading, will shape the fate of injected particles in ways no fibroblast monoculture can fully predict. Long-term studies of degradation, migration and nodule formation will be essential before porous PCL microspheres can be proposed for human use. Still, the study delivers something the field has lacked: a clean, controlled demonstration that porosity itself, engineered through microfluidics, amplifies the collagen-stimulating capacity of a proven filler polymer. As demand grows for fillers that regenerate tissue rather than simply fill it, manufacturing precision of this kind is likely to become the standard against which next-generation products are judged.

Subject of Research: Microfluidic fabrication of porous polycaprolactone microspheres as collagen-stimulating dermal fillers

Article Title: Microfluidic preparation of porous polycaprolactone microspheres as dermal fillers with enhanced collagen secretion

Article References: Zhang, J., Li, Y., Ye, J., & Cen, L. (2026). Microfluidic preparation of porous polycaprolactone microspheres as dermal fillers with enhanced collagen secretion. Archives of Dermatological Research, 318(1), Article 436. https://doi.org/10.1007/s00403-026-04944-6

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04944-6

Keywords: polycaprolactone, microfluidics, porous microspheres, dermal fillers, collagen synthesis, fibroblasts, skin aging, biostimulatory fillers, tissue engineering, interleukin-6, biomaterials, regenerative medicine

The biological logic behind the research begins with tyrosinase, a copper-containing oxidase that catalyzes the first steps of melanin biosynthesis. When tyrosinase runs unchecked, melanin is overproduced, producing the dark patches characteristic of melasma, age spots, and post-inflammatory hyperpigmentation, conditions whose prevalence is growing as climate change intensifies ultraviolet exposure worldwide. Existing inhibitors such as kojic acid, arbutin, and hydroquinone are widely used but suffer from low stability, poor selectivity, and adverse effects with prolonged use, leaving dermatologists and cosmetic chemists searching for better scaffolds. Excessive tyrosinase activity has also been linked to oxidative stress and cellular damage, which means that an ideal inhibitor would ideally mop up reactive oxygen species at the same time.

But tyrosinase is only one actor in the aging drama. Three additional enzymes—elastase, collagenase, and hyaluronidase—systematically dismantle the extracellular matrix that keeps skin firm, elastic, and hydrated. Elastase degrades elastin, collagenase breaks down collagen, and hyaluronidase chops up hyaluronic acid, the molecule responsible for the skin’s moisture retention and plumpness. Their activation, triggered largely by reactive oxygen species, produces the wrinkles, dryness, and loss of firmness we recognize as skin aging. Because these processes run in parallel, the research team argued that a truly effective anti-aging compound should hit multiple targets at once rather than attacking a single pathway, and they turned to the coumarin scaffold as the foundation for such a multitarget agent.

Coumarins, an aromatic class of plant-derived compounds with a long history in dermatology, are structurally versatile: adding different substituents changes the electronic properties of the core and, with them, both antioxidant capacity and the ability to grip enzyme active sites. Building on years of prior work in which the group screened its in-house chemical library and identified 3-arylcoumarins with micromolar tyrosinase activity, the researchers used structure–activity relationships and molecular docking to design a new series. They strategically installed hydroxyl groups on the coumarin nucleus—because hydrogen-bond donors and acceptors strengthen binding to the tyrosinase catalytic site—and nitro groups on the 3-phenyl ring, exploiting the nitro group’s strong electron-withdrawing character to tune the molecule’s electronics and orientation within the enzyme pocket.

The synthesis relied on the Perkin-Oglialoro reaction, a two-step condensation the group has refined over several years. In the first step, a hydroxy-substituted phenylacetic acid and a hydroxylated salicylaldehyde are refluxed in acetic anhydride with potassium acetate, closing the coumarin ring while simultaneously acetylating the free hydroxyl groups. Ring closure is confirmed by the characteristic H-4 proton in the proton NMR spectrum. The second step hydrolyzes these acetyl groups in aqueous hydrochloric acid and methanol, releasing the free hydroxyl derivatives, whose low-field hydroxyl protons verify the final products. All eighteen compounds were fully characterized by proton and carbon NMR and mass spectrometry, providing the chemical foundation for the biological campaign that followed.

The biological results were dramatic. Of the eighteen compounds tested, six inhibited tyrosinase, and three did so far more potently than kojic acid, the standard inhibitor with an IC50 of 17.9 micromolar. The standout was compound 12, 6,7-dihydroxy-3-(4-nitrophenyl)coumarin, which inhibited the enzyme at an IC50 of just 0.9 micromolar—roughly twenty times more potent than kojic acid. Compounds 17 and 18, both 5,7-dihydroxy-3-(nitrophenyl)coumarins, followed at 2.6 and 5.7 micromolar, about seven-fold and three-fold better than the standard. The structure–activity relationship is telling: the 6,7-dihydroxy catechol arrangement paired with a para-nitrophenyl group proved optimal, and comparing compounds 17 and 18 showed that even the position of a single nitro group—meta versus para—shifts the biological response, likely by altering electron distribution and the orientation of the aryl ring in the binding site.

The three lead compounds were then tested against the extracellular-matrix-degrading enzymes, and here the multitarget promise truly materialized. All three inhibited elastase, with compound 18 matching the reference inhibitor oleanolic acid at 20.5 micromolar. Against collagenase, all three derivatives recorded IC50 values statistically lower than the epigallocatechin gallate reference, with compound 18 reaching 124.6 micromolar. The most striking results came from hyaluronidase: compounds 12, 17, and 18 were 7.6-, 4.4-, and 4.4-fold more potent than oleanolic acid, respectively, with compound 12 active at 27.8 micromolar. Together, these data show that a single 3-arylcoumarin framework can suppress the entire enzymatic cascade that degrades collagen, elastin, and hyaluronic acid.

Antioxidant and photoprotective assays rounded out the profile. In ABTS and DPPH radical-scavenging assays, four compounds were active in both tests, and in the DPPH assay their EC50 values were significantly lower than that of Trolox, the vitamin E derivative used as the antioxidant benchmark. Compound 12 again distinguished itself, combining strong radical scavenging with the highest sun protection factor of the series, measured by UV spectrophotometry across the 290 to 320 nanometer range using the Mansur equation. Crucially, when the compound was applied to HaCaT human keratinocytes—a well-established in vitro model of the human epidermis—at concentrations from 1 to 25 micromolar for 24 hours, an MTT viability assay showed no cytotoxicity, an essential early safety signal for any topical candidate.

Molecular docking explained why compound 12 works so well. Using the crystal structure of tyrosinase from Agaricus bisporus, the team validated their protocol by re-docking the co-crystallized inhibitor tropolone, achieving a root-mean-square deviation of 1.373 angstroms, well within the reliability threshold. The predicted pose of compound 12 places its 7-hydroxyl oxygen within coordinating distance of one of the two catalytic copper ions, forming a coordination bond that would block natural substrates from entering the catalytic site and halt the monophenolase and diphenolase reactions that ultimately polymerize into melanin. The predicted binding energy of −7.9 kilocalories per mole for compound 12, and −8.7 and −8.6 for compounds 17 and 18, compares favorably with tropolone’s −6.0, and ligand efficiencies above 0.3 kilocalories per mole per heavy atom mark all three as fragment-like hits ripe for optimization. Docking also revealed that a meta-nitro group, as in compound 17, enables a hydrogen bond with the conserved residue ASN260 near the binuclear copper center, an interaction absent in the para-nitro analogues.

The authors are careful to frame their structure–activity analysis as a working hypothesis rather than proof of mechanism; enzyme kinetics and biophysical structural studies will be needed to confirm the precise interactions. Even so, the convergence of evidence is compelling: compound 12 inhibits tyrosinase at nanomolar-to-low-micromolar levels, suppresses elastase, collagenase, and hyaluronidase, scavenges free radicals, absorbs ultraviolet radiation, and spares human keratinocytes. As hyperpigmentation disorders spread with a warming climate and consumers demand safer alternatives to hydroquinone, this catechol-nitrophenyl coumarin offers a rare combination of potency, breadth, and preliminary safety. The next step—optimizing the lead into a candidate suitable for formulation and preclinical testing—will determine whether a single synthetic molecule can genuinely hold back the multiple clocks of skin aging at once.

Subject of Research: Design and biological evaluation of multitarget 3-arylcoumarin compounds inhibiting skin aging-related enzymes

Article Title: Multifunctional compounds for the treatment of skin diseases: synthesis, inhibition of skin aging-related enzymes, docking studies, and antioxidant activity

Article References: Floris, S., Era, B., Pintus, F., Fais, A., Novás, M., & Matos, M. J. (2026). Multifunctional compounds for the treatment of skin diseases: synthesis, inhibition of skin aging-related enzymes, docking studies, and antioxidant activity. Results in Chemistry, 31, Article 103941. https://doi.org/10.1016/j.rechem.2026.103941

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103941

Keywords: coumarin, tyrosinase, skin aging, hyperpigmentation, elastase, collagenase, hyaluronidase, antioxidant, molecular docking, sun protection factor, medicinal chemistry, keratinocytes

The researchers began with a straightforward hypothesis grounded in clinical observation. Solar lentigines are characterized by persistent basal hyperpigmentation, meaning that the deepest layer of the epidermis remains loaded with melanin long after the original sun exposure that triggered it. They proposed that a sustained stress response centered on IRE1α, a sensor protein embedded in the endoplasmic reticulum membrane, could act on both sides of the pigment equation at once. IRE1α is best known as a key initiator of the unfolded protein response, a cellular quality-control program that activates when misfolded proteins accumulate. When the stress is brief, the response is protective; when it becomes chronic, it can push cells toward senescence, a state of permanent growth arrest.

To test the idea, the team combined human tissue analysis with mechanistic experiments in cell culture. They examined paired samples of lesional and non-lesional skin from patients with solar lentigines, work approved by the Institutional Review Board of Severance Hospital, and complemented the histology with two laboratory models: MNT-1 melanocytes, the pigment-producing cells of the skin, and HaCaT keratinocytes, the cells that form the bulk of the epidermis and normally receive and degrade transferred melanosomes. Crucially, the keratinocyte model included a doxycycline-inducible system as well as constitutive IRE1α expression, allowing the researchers to switch the stress pathway on at will and observe the consequences in a controlled manner.

The tissue findings set the stage. In lesional epidermis, the investigators observed dense accumulations of stage-IV melanosomes, the fully mature, heavily pigmented organelles that melanocytes manufacture and hand off to keratinocytes. Alongside this pigment load, the stressed skin showed elevated levels of IRE1α and p16, a canonical marker of cellular senescence. This co-occurrence was the first hint that the two phenomena, aging-like growth arrest and pigment retention, might share a common driver rather than being parallel but independent consequences of sun damage.

Experiments in the cell models then dissected the mechanism in detail. When the researchers sustained IRE1α signaling, cell proliferation dropped and the senescence markers p16 and p21 rose, confirming that chronic endoplasmic reticulum stress is sufficient to push these epidermal cells into a senescent state. In the melanocytes, the consequences for pigmentation were direct and measurable: IRE1α activation increased tyrosinase activity, the rate-limiting enzymatic step of melanin synthesis, and raised total melanin content. The cells also produced more melanosomes, and those melanosomes were larger than normal, expanding the raw supply of pigment available for transfer to surrounding keratinocytes.

The second half of the dual-hit mechanism emerged from the keratinocyte experiments. Keratinocytes are not passive pigment containers; they are supposed to degrade the melanosomes they receive through lysosomal pathways, a process sometimes described as melanophagy. Under sustained IRE1α signaling, that degradation slowed markedly. The researchers quantified intracellular melanosomes and found they accumulated because they were being broken down more slowly, not because more were arriving. Probing the lysosomal system, they detected diminished LysoTracker signal, indicating reduced lysosomal acidity, along with reduced maturation of cathepsin-B, a key degradative enzyme that requires an acidic environment to become fully active. Autophagic flux, measured with a mRFP–GFP–LC3 reporter that distinguishes early autophagosomes from mature autolysosomes, was also compromised, with fewer autolysosomes forming.

Together, these results sketch a coherent pathological circuit. Chronic IRE1α signaling in melanocytes ramps up melanogenesis, flooding the epidermis with pigment, while the same stress pathway in keratinocytes weakens the lysosomal machinery responsible for clearing that pigment away. The senescent state that accompanies the stress response likely stabilizes the situation, since senescent cells persist in tissue rather than being replaced, maintaining the altered signaling environment over time. The net effect is that pigment is produced faster and cleared more slowly, exactly the combination needed to explain the dense, persistent basal hyperpigmentation that defines solar lentigines.

The study also points toward intervention. The researchers tested two agents: verapamil, a calcium channel blocker better known as a cardiovascular drug, and STF083010, a selective inhibitor of the IRE1α RNase domain, the enzymatic activity through which IRE1α transmits its stress signal. Both compounds lessened melanosome accumulation in the keratinocyte model and partially restored degradative function. While the restoration was partial, the finding is significant because it demonstrates that the pigment-retention phenotype is not irreversible and that the IRE1α–lysosome axis is a plausible therapeutic target. Existing treatments for solar lentigines, such as laser therapy and topical depigmenting agents, aim primarily at melanin production or destruction; a strategy that instead restores the clearance machinery would represent a fundamentally different approach.

The broader implications extend beyond cosmetically visible age spots. The unfolded protein response has been implicated in a wide range of age-related tissue changes, and this study adds a vivid example of how a single stress sensor can couple senescence to a tissue-specific functional outcome, in this case pigmentation. The work also highlights melanophagy as an underappreciated control point in skin color biology. Most research on hyperpigmentation has focused on melanocytes and their synthetic output, but the fate of melanosomes after transfer is equally decisive, and lysosomal acidification and cathepsin maturation emerge from this study as actionable levers. If the findings hold up in further clinical studies, modulating IRE1α activity or supporting lysosomal function could inform the development of treatments not only for solar lentigines but potentially for other disorders of pigment retention.

The research, funded by the National Research Foundation of Korea, Yonsei University College of Medicine and the Korea Health Technology R&D Project, was published as an open-access article and is citable under DOI 10.1007/s00018-026-06389-6. Its central message is elegant in its economy: one stress pathway, acting chronically, produces pigment faster and disposes of it more slowly, while locking the affected cells into senescence. For the millions of people who develop these stubborn brown patches, the study offers something more concrete than a new description of the problem, namely a defined molecular axis that can, at least in laboratory models, be pharmacologically nudged back toward balance. Translating that laboratory result into safe and effective clinical therapy will require further work, but the identification of the IRE1α and lysosome axis as a coupled driver of senescence and pigment retention gives the field a clear and testable direction.

Subject of Research: Chronic endoplasmic reticulum stress linking cellular senescence to persistent skin hyperpigmentation in solar lentigines

Article Title: Chronic ER stress couples cellular senescence with pigment retention

Article References: Hwang, S., Kim, J. Y., Lee, E. J., Oh, D., Bae, Y. J., Kwon, I. J., Park, S., Seo, H. R., Alqahtani, J., Lee, J., & Oh, S. H. (2026). Chronic ER stress couples cellular senescence with pigment retention. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06389-6

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06389-6

Keywords: solar lentigo, IRE1α, unfolded protein response, ER stress, cellular senescence, melanophagy, melanogenesis, lysosomal acidification, keratinocytes, melanocytes, p16, skin aging

The research team began by isolating and characterizing the bioactive constituents of both plants using ultra-filtration high-performance liquid chromatography coupled with diode-array detection, known as UF-HPLC-DAD, alongside Fourier-transform infrared spectroscopy. This analytical pairing allowed the researchers to identify several distinct molecules within the extracts, including viscic acid, pasakbumin C, a series of 8′Z-enyl congeners, 5-(8′Z,11′Z-heptadecadienyl)-1,3-benzenediol, 9′-(o-methyl) protocetraric acid, and calophynic acid. Each of these compounds belongs to chemical classes known to interact with proteins, and the ultra-filtration step in particular is designed to enrich for ligands that bind target enzymes, giving the team a shortlist of candidates whose biological activity could then be tested directly.

The enzymatic targets chosen for the study read like a checklist of the molecular machinery behind visible skin aging. Tyrosinase, the copper-containing enzyme that catalyzes the first steps of melanin biosynthesis, exists in two catalytic modes: monophenolase activity, which hydroxylates tyrosine, and diphenolase activity, which oxidizes the resulting dihydroxyphenylalanine. Overactive tyrosinase underlies hyperpigmentation disorders such as melasma and age spots. Meanwhile, collagenase and elastase break down collagen and elastin respectively, the structural proteins that give skin its firmness and recoil, and hyaluronidase degrades hyaluronic acid, the glycosaminoglycan responsible for much of the skin’s hydration and volume. Inhibiting all four simultaneously is a multi-target strategy that single-molecule drugs rarely achieve.

The results were striking, particularly for Adhatoda vasica. Leaf extracts of the plant, a shrub widely used in Ayurvedic medicine and commonly known as malabar nut, exhibited potent tyrosinase inhibition, with an IC₅₀ value of 22.16 micrograms per milliliter against the monophenolase reaction and 15.5 micrograms per milliliter against the diphenolase reaction. IC₅₀ values express the concentration of inhibitor needed to halve enzyme activity, so lower numbers indicate stronger inhibition, and values in the low tens of micrograms per milliliter represent meaningful potency for crude plant extracts. Calotropis procera, the so-called apple of Sodom or giant milkweed, also demonstrated significant inhibitory activity against the same enzyme, suggesting that the two plants converge on similar biochemical targets despite their very different phytochemical profiles.

Beyond tyrosinase, both extracts showed appreciable inhibition of collagenase, elastase, and hyaluronidase, along with measurable antioxidant activity. This combination matters because the degradation of the skin’s extracellular matrix is not a single-enzyme event. Matrix metalloproteinases and related hydrolases work in concert, and oxidative stress amplifies their activity by damaging the very structural components they target and by activating inflammatory signaling. An extract that simultaneously restrains several of these enzymes while neutralizing reactive oxygen species could, in principle, offer layered protection against the cumulative damage that manifests as wrinkles, sagging, and loss of skin elasticity. The authors suggest this protective potential extends to guarding the extracellular matrix against enzymatic degradation and oxidative damage more broadly.

To test whether these biochemical effects translate into cellular activity, the team turned to dermal fibroblasts, the cells that synthesize collagen and maintain the dermal scaffold. Cytotoxicity was assessed using lactate dehydrogenase release assays, a standard measure of membrane damage in which the enzyme LDH leaks out of cells whose plasma membranes have been compromised. The assays confirmed concentration-dependent effects, meaning that the extracts’ impact on cell viability changed systematically with dose, an important parameter for any candidate topical ingredient since it defines the window between a therapeutically useful concentration and a harmful one.

The cellular work went further than viability alone. Using scanning and transmission electron microscopy, the researchers examined the ultrastructure of fibroblasts exposed to the extracts and observed distinct morphological changes. These included alterations in cell wall integrity, cytoplasmic organization, and intercellular structure. Electron microscopy at this resolution can reveal subcellular rearrangements that light microscopy misses, and the observed changes indicate that the extracts are genuinely bioactive at the cellular level rather than inert. The authors interpret these findings as evidence of both protective and bioactive cellular effects, though the precise mechanisms linking specific molecules to specific ultrastructural changes remain to be worked out.

The study’s significance lies partly in its methodology. By coupling ligand-targeted analytical chemistry with a panel of enzyme assays and cellular imaging, the researchers moved beyond the simple antioxidant screening that dominates much of the natural products literature. The identification of named compounds such as viscic acid and pasakbumin C provides concrete chemical starting points for follow-up work, whether that involves testing purified molecules individually, exploring structure-activity relationships, or investigating synergy among the extract components. Synergistic action among plant-derived compounds has been proposed as a key reason why whole extracts sometimes outperform isolated single agents against skin-infecting microorganisms and other targets, and the multi-enzyme profile observed here is consistent with a mixture of compounds acting on overlapping pathways.

Both plants carry cultural and pharmacological baggage that any future development would need to address. Adhatoda vasica has been used for centuries in traditional respiratory medicine, while Calotropis procera is known to produce toxic cardenolides and irritant latex, which makes the safety profiling in this study, including the LDH cytotoxicity data, particularly relevant. The concentration-dependent cytotoxicity results suggest that formulation scientists would need to identify the dose range at which enzyme inhibition and matrix protection are achieved without harming fibroblasts. Standardizing extracts to specific active compounds, and potentially removing or minimizing toxic constituents, would be a logical next step toward topical preparations aimed at managing skin disorders and preventing enzymatic skin degradation.

For now, the findings position A. vasica and C. procera as promising sources of bioactive compounds with potential applications in dermatological formulations, from anti-hyperpigmentation treatments to products designed to preserve the structural integrity of aging skin. The work was funded by Umm Al-Qura University in Saudi Arabia under grant number 26UQU4430043GSSR12, and the authors report no competing interests. As with all in vitro studies, the gap between enzyme inhibition in a test tube and clinically meaningful results in human skin is substantial, and the researchers themselves frame the results as a foundation for dermatological applications rather than a demonstration of therapeutic efficacy. Still, in a field where consumers increasingly demand plant-derived actives backed by mechanistic evidence, a study that names its molecules, quantifies its enzyme inhibition, and images its cellular effects offers a template for how traditional medicinal plants can be rigorously evaluated for modern skincare science.

Subject of Research: Natural multi-target enzyme inhibitors from Adhatoda vasica and Calotropis procera for dermal regeneration

Article Title: Natural multi-target inhibitors from Adhatoda vasica and Calotropis procera for dermal regeneration

Article References: Ahmed, W., Azmat, R., Qayyum, A., Abbas, H., & Ramadan, M. F. (2026). Natural multi-target inhibitors from Adhatoda vasica and Calotropis procera for dermal regeneration. The Science of Nature, 113(5), Article 122. https://doi.org/10.1007/s00114-026-02170-8

Image Credits: AI Generated

DOI: 10.1007/s00114-026-02170-8

Keywords: Adhatoda vasica, Calotropis procera, tyrosinase inhibition, collagenase, elastase, hyaluronidase, skin aging, dermal fibroblasts, UF-HPLC, FTIR, natural products, dermatology

Foxn1, short for Forkhead box N1, belongs to a large family of transcription factors that bind DNA and switch other genes on or off. The gene first earned scientific fame because mutations in it cause nude mice to be hairless and immune-deficient, a phenotype traced to failed development of the thymus and hair follicles. In humans, mutations in FOXN1 produce a rare form of severe combined immunodeficiency accompanied by alopecia and nail dystrophy. What the new study adds is a systematic portrait of what happens when Foxn1 dosage is halved in otherwise healthy animals and how that half-dose interacts with aging itself.

The researchers worked with three groups of animals: young mice at twenty days of age, middle-aged mice at one year, and old mice at two years. At each time point they compared wild-type animals, carrying two normal copies of Foxn1, with heterozygous knockout animals carrying only one. Because no live-animal procedures were involved, the team collected tissue post-mortem, in accordance with European Directive 2010/63/EU. They then applied a battery of techniques ranging from histology and immunofluorescence to western blotting and quantitative PCR, supplemented by liquid chromatography with tandem mass spectrometry, to build a layered picture of gene expression, protein abundance, and tissue structure.

The morphological differences were striking. Skin from the heterozygous animals had a thinner epidermis and a thicker dermis than that of their wild-type counterparts. Within the epidermis, keratinocyte differentiation was disrupted, with an enlarged spinous layer dominating the tissue. The spinous layer is the thick middle stratum of the epidermis where differentiating keratinocytes are held together by numerous desmosomes, giving the cells their spiny appearance under the microscope. Its expansion in Foxn1 haploinsufficient mice points to a shift in how basal cells exit the proliferative compartment and mature into the protective barrier layers above, a process governed by a finely tuned sequence of lineage-specific keratins and terminal differentiation markers such as keratin 10, loricrin, and filaggrin.

Collagen composition told an equally intriguing story. Wild-type skin accumulated more collagen I, the stiff, rope-like fiber that provides tensile strength and is characteristic of mature, repair-oriented extracellular matrix. Heterozygous skin, by contrast, maintained elevated levels of collagen III, the thinner, more pliable fiber that dominates embryonic and regenerative tissue and is normally replaced by collagen I during scar maturation. This shift hints that reduced Foxn1 dosage preserves a more regeneration-friendly matrix profile, a property of considerable interest for wound-healing and anti-aging research, where the goal is often to coax adult skin back toward a fetal-like repair mode rather than a scarring one.

Perhaps the most consequential finding concerned cellular senescence, the state of stable cell-cycle arrest that accumulates in aging tissues and drives inflammation through the molecules senescent cells secrete. The team measured expression of p21, encoded by the Cdkn1a gene, a canonical readout of senescence signaling. In wild-type mice, p21 expression climbed steadily with age, exactly as expected for tissue progressively filling with senescent cells. In the heterozygous mice, however, p21 remained low even in aged animals, suggesting that halving Foxn1 dosage fundamentally alters the senescence pathway in skin. The authors are careful to frame this as an altered trajectory rather than proven rejuvenation, but the implication is provocative: a transcription factor could reprogram how skin cells respond to the molecular damage of time.

Foxn1 also emerged as a modulator of the hypoxia response and of redox homeostasis, the biochemical balancing act between reactive oxygen species and the antioxidant systems that neutralize them. Reactive oxygen species are unavoidable byproducts of mitochondrial metabolism and, when unchecked, damage lipids, proteins, and DNA, making redox balance a cornerstone of aging biology. The researchers examined HIF-1α, the hypoxia-inducible factor that coordinates cellular responses to low oxygen, along with factor inhibiting HIF-1, the oxygen-dependent hydroxylase that switches HIF signaling off. They also profiled the thioredoxin system, including thioredoxins 1 and 2 and their reductases Txnrd1 through Txnrd3, plus sulfiredoxin 1, all central components of the cellular antioxidant arsenal. Differences in these pathways between the genotypes were most pronounced in young and middle-aged animals, and notably faded in the oldest group.

That age-dependent fading is itself an important message. The regulatory influence of Foxn1 on hypoxia signaling, oxidative stress, and cellular protection appears strongest when the skin is still youthful and wanes as animals reach advanced age. In other words, Foxn1 behaves like an age-sensitive governor: in early and mid-life it helps hold skin homeostasis in check, but by two years of age its grip loosens, and the aging phenotype proceeds regardless of genotype. This dynamic complicates any simple therapeutic narrative, because simply knowing that a gene matters is not enough; the timing of its activity defines when an intervention might work.

The study also documented Foxn1 protein inside epidermal keratinocytes and hair follicles in both genotypes and at all three ages, using immunofluorescence and transgenic FOXN1::eGFP reporter mice generously provided by Professor Thomas Boehm of the Max Planck Institute of Immunobiology and Epigenetics. The nuclear localization of the protein within keratinocytes is consistent with its established function as a DNA-binding transcription factor and supports the idea that Foxn1 acts directly within the epidermal lineage rather than merely indirectly through immune or dermal effects. Hair follicle counts in the dermis and in the dermal white adipose tissue, the fat layer under the skin that hosts follicle bulges, further mapped how structural changes distribute across skin compartments with age and genotype.

For a broad audience, the takeaway is that skin aging is not a one-way slide but a genetically choreographed process with named conductors. Foxn1 now joins the short list of genes whose dosage measurably reshapes tissue structure, extracellular matrix composition, senescence signaling, and stress responses in an intact aging organism. Because the work was performed in mice, translating it to human skin will require caution; human and murine skin differ in thickness, follicle density, and immune composition. Still, the identification of a single transcription factor whose partial loss keeps p21 low and preserves a regenerative collagen profile gives aging researchers a concrete molecular handle. Whether pharmacologically tuning Foxn1 activity could one day slow skin aging or improve wound repair remains an open question, but this study transforms it from speculation into a testable hypothesis, and it does so with the kind of multi-system, age-resolved evidence that the field has long demanded.

Subject of Research: The role of the Foxn1 transcription factor in skin structure, redox balance, and aging

Article Title: Foxn1 regulates epidermal structure, redox balance, and age related changes

Article References: Machcinska-Zielinska, S., Kopcewicz, M., Wisniewska, J., Valdivieso, K., Ogrodnik, M., Walendzik, K., & Gawronska-Kozak, B. (2026). Foxn1 regulates epidermal structure, redox balance, and age related changes. BMC Biology. https://doi.org/10.1186/s12915-026-02737-x

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02737-x

Keywords: Foxn1, skin aging, epidermis, keratinocytes, collagen, redox homeostasis, reactive oxygen species, senescence, p21, HIF-1 alpha, thioredoxin, mice

The authors frame skin aging as a two-front battle. Intrinsic aging unfolds over time through genetic and metabolic factors, producing atrophy, dryness and fine lines in areas the sun never touches. Extrinsic aging is driven by the environment, and ultraviolet radiation dominates it, accounting for roughly 80 percent of visible signs of skin aging. UVB rays, spanning 280 to 320 nanometres, strike the epidermis and can directly damage DNA, while longer UVA wavelengths penetrate to the dermis and generate reactive oxygen species that corrode cellular machinery. The hallmark of this photoaging is solar elastosis, an abundance of pathologically altered elastic fibres that leaves chronically sun-exposed skin leathery and lax. Air pollution and smoking add further oxidative insult, but it is the interplay between external damage and internal cellular failure that the review places at the centre of the story.

That interplay plays out through four principal cell types. Fibroblasts, the workhorses of the dermis, synthesize type I and type III collagen and elastin, the structural proteins that keep skin firm and resilient. When fibroblasts senesce, they stop producing these components and instead secrete matrix metalloproteinases, enzymes that chew through the extracellular matrix. The result is dermal atrophy, reduced elasticity and wrinkling. Intriguingly, fibroblast senescence has a dual character in wound healing: in young mice, a transient wave of senescent fibroblasts secretes platelet-derived growth factor AA that drives myofibroblast differentiation and efficient wound closure, but as p21-positive senescent fibroblasts accumulate with age, proliferation stalls and repair is delayed. Senescent myofibroblasts also reduce expression of alpha-smooth muscle actin, a key contractile protein, undermining wound contraction and limiting fibrosis in ways that complicate healing in older tissue.

Macrophages add an inflammatory dimension. These immune cells normally clear debris and pathogens, with pro-inflammatory M1 macrophages dominating the early phase of wound repair and anti-inflammatory M2 macrophages steering the transition to tissue rebuilding. In aged skin, this balance tips: macrophages show reduced proliferative and phagocytic capacity, polarization shifts toward M1, and pro-inflammatory gene expression rises. The consequences for structure are concrete—fewer M2 cells mean reduced synthesis of collagen types I, V and VI, while excess M1 activity ramps up metalloproteinase-mediated collagen degradation. Keratinocytes, the dominant epidermal cell, slow their renewal with senescence, thinning the epidermis, increasing moisture loss and opening the door to pathogens such as Staphylococcus aureus. Epidermal stem cells, meanwhile, lose the proliferative vigour needed for re-epithelialization; reduced PGC-1α impairs their differentiation in aged mice, and an age-related decline in SIRT7 disrupts Nfatc1-mediated quiescence of hair follicle stem cells, contributing to the hair thinning so characteristic of aging skin.

At the molecular level, the review identifies reactive oxygen species and DNA damage as primary instigators. Excess ROS activate the transcription factors AP-1 and NF-κB through MAPK signalling, driving expression of matrix metalloproteinases that degrade collagen and elastin while simultaneously suppressing synthesis of new matrix components. The damage feeds on itself: fragmented collagen reduces the mechanical resistance of the extracellular matrix, lowering tension inside fibroblasts, which impairs their function and spurs further ROS production—a positive feedback loop that accelerates aging. ROS also oxidize DNA bases and break strands, and although repair pathways such as nucleotide excision repair and base excision repair normally respond, excessive oxidative stress can damage the repair machinery itself. Persistent DNA damage signalling activates ATM and ATR kinases, triggering the p53–p21 axis that locks cells into permanent cycle arrest and senescence, complete with the senescence-associated secretory phenotype.

The SASP is where individual senescent cells become a tissue-wide problem. Senescent cells resist apoptosis, evade immune clearance and broadcast inflammatory cytokines, growth factors and extracellular vesicles to their neighbours. Among the messengers, TGF-β normally drives collagen synthesis through Smad2/3 signalling, but photoaging reduces TGF-β receptor expression and UV radiation induces the inhibitory Smad7, choking off matrix production. IL-1α, stored in keratinocytes and released by UV exposure, activates the IRAK–TRAF6–TAK1 cascade, igniting NF-κB and inducing IL-6 and IL-8—while NF-κB in turn upregulates IL-1α, creating a self-amplifying inflammatory loop. Perhaps most striking are the extracellular vesicles: senescent cells release more of them, and these vesicles can carry toxic nuclear DNA fragments that induce senescence in recipient cells via the cGAS–STING pathway, as well as microRNAs such as miR-30a, miR-326-3p and miR-451a that suppress proliferation, promote fibroblast senescence and elevate ROS. Senescence, in effect, is contagious.

The review also highlights an epigenetic layer: histone modifications that govern macrophage polarization in aging wounds. The demethylase JMJD3 promotes early inflammatory M1 responses by removing the repressive H3K27me3 mark, but in diabetic wounds its sustained overexpression prolongs NF-κB-driven inflammation and delays healing. SETDB2-mediated H3K9me3 normally represses inflammatory genes and favours M2 polarization, yet it is downregulated in diabetic tissue. Persistent MOF-driven H4K16 acetylation sustains inflammatory transcription, and the age-associated histone lactylation mark H3K18La has been shown to activate NF-κB signalling at the promoters of p65 and p50. These findings suggest that aging skews the epigenetic landscape of immune cells in ways that trap wounds in a chronic inflammatory state, offering new targets for intervention.

On the therapeutic front, senotherapeutics lead the charge, divided into senolytics that kill senescent cells and senomorphics that neutralize their secretions. Navitoclax (ABT-263) inhibits anti-apoptotic BCL-2 family proteins, selectively eliminating senescent dermal fibroblasts, reducing MMP secretion and improving wound healing, though senescent melanocytes protected by MCL-1 resist it and side effects including thrombocytopenia demand caution. The flavonoids quercetin and fisetin induce apoptosis through PI3K/AKT inhibition, with the dasatinib–quercetin combination showing clinical promise for removing senescent fibroblasts, and fisetin additionally suppressing TNF-α, IL-1β, IL-6 and MMPs via NF-κB and MAPK/AP-1 blockade. Rutin, a senomorphic flavonoid, reduced wrinkle length and improved elasticity in a randomized double-blind trial while scavenging ROS and activating Nrf2 defences. Rapamycin suppresses the mTOR-driven SASP, enhances autophagy and directly activated TGF-β receptors in a trial showing increased dermal collagen and improved fine lines, while metformin activates AMPK to inhibit mTOR, reduce collagen-damaging oxidative stress and accelerate wound healing.

Stem cell therapy offers a complementary regenerative route. Mesenchymal stem cells can differentiate into keratinocyte lineages, and their secretomes—rich in GDF-11, TGF-β1, FGF family members, EGF, VEGF and HGF—stimulate fibroblast proliferation, collagen synthesis, angiogenesis and hair growth. Clinical trials using microneedling to deliver adipose-derived stem cell secretomes, umbilical cord-conditioned media and amniotic membrane preparations have reported significant improvements in wrinkles, elasticity, hydration and pigmentation. Stem cell-derived extracellular vesicles transfer TIMP1 to inhibit matrix-degrading enzymes, carry antioxidant peroxiredoxins and can push macrophages toward anti-inflammatory states. Delivery remains a bottleneck—the skin barrier limits penetration of most compounds—but liposomes, solid lipid nanoparticles, hydrogel-encapsulated systems and EV-based dual-loading carriers are extending how deeply and stably anti-aging agents reach their targets.

Perhaps the most forward-looking section concerns artificial intelligence. With traditional drug development slow and costly, machine learning models trained on labelled compound datasets are compressing discovery timelines dramatically. One XGBoost model screened more than 4,000 compounds and identified ginkgetin, periplocin and oleandrin as validated senolytics; an ensemble predictor combining a support vector machine and multilayer perceptron surfaced panaxatriol and voclosporin from hundreds of database candidates. The authors argue that integrating multi-omics data with AI could resolve the cellular heterogeneity that currently limits senolytic precision, though they caution that high-resolution spatial transcriptomic datasets for human skin remain scarce. For a field in which few candidates have reached Phase III trials, the convergence of senolytic chemistry, stem cell secretomes, nanoscale delivery and AI-driven screening may prove the combination that finally turns the biology of skin aging into treatable medicine.

Subject of Research: Molecular mechanisms of skin aging and emerging senotherapeutic, stem cell and AI-based interventions

Article Title: Skin Aging: From Molecular Mechanisms to Therapeutic and Technological Innovations

Article References: Chen, S., Yang, Y., Pan, X., Pan, Y., & Cai, S. (2026). Skin Aging: From Molecular Mechanisms to Therapeutic and Technological Innovations. Journal of Cellular and Molecular Medicine, 30(18), Article e71357. https://doi.org/10.1111/jcmm.71357

Image Credits: AI Generated

DOI: 10.1111/jcmm.71357

Keywords: skin aging, cellular senescence, SASP, senolytics, photoaging, reactive oxygen species, extracellular vesicles, macrophage polarization, mesenchymal stem cells, rapamycin, nanocarriers, machine learning